BioWorld

Dec. 13, 2002

Intracel Climbs From Bankruptcy, Raises $16M In Series B Round

Intracel Holdings Corp., newly formed with the assets from bankrupt Intracel Corp., said it completed a first closing of its Series B convertible preferred stock offering, bringing in $16 million. (BioWorld Today) Read More

Neurochem Raises C$8M, Could Realize More With Warrants Sale

Alone Among Mammals, Zebrafish Repair, Replace Own Injured Heart, With Nod To Future Human Clients

Inhale Cutting Staff As Part Of Plan To Focus Programs

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026